Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.6387 | 0.6387 |
Schistosoma mansoni | inhibitor of apoptosis protein | 0.0065 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0029 | 0.2862 | 0.2862 |
Echinococcus granulosus | lamin | 0.0029 | 0.2862 | 0.2862 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.2862 | 0.2862 |
Echinococcus multilocularis | musashi | 0.0029 | 0.2862 | 0.2862 |
Echinococcus multilocularis | inhibitor of apoptosis protein | 0.0065 | 1 | 1 |
Schistosoma mansoni | inhibitor of apoptosis (iap) domain family member | 0.0065 | 1 | 1 |
Onchocerca volvulus | 0.0065 | 1 | 1 | |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.6387 | 0.6387 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.0065 | 1 | 1 |
Echinococcus multilocularis | baculoviral IAP repeat containing protein | 0.0065 | 1 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.6387 | 0.6387 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0029 | 0.2862 | 0.2646 |
Echinococcus granulosus | baculoviral IAP repeat containing protein | 0.0065 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.6387 | 0.4938 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.2761 | 0.2761 |
Echinococcus multilocularis | lamin | 0.0029 | 0.2862 | 0.2862 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0047 | 0.6387 | 0.6387 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.6387 | 0.6387 |
Echinococcus granulosus | intermediate filament protein | 0.0029 | 0.2862 | 0.2862 |
Schistosoma mansoni | hypothetical protein | 0.0065 | 1 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0047 | 0.6387 | 0.6277 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.6387 | 0.4938 |
Loa Loa (eye worm) | intermediate filament protein | 0.0029 | 0.2862 | 0.2862 |
Brugia malayi | intermediate filament protein | 0.0029 | 0.2862 | 0.2646 |
Onchocerca volvulus | Deterin homolog | 0.0065 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 1 | 1 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0015 | 0.0294 | 0.0294 |
Echinococcus multilocularis | lamin dm0 | 0.0029 | 0.2862 | 0.2862 |
Echinococcus granulosus | inhibitor of apoptosis protein | 0.0065 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.6387 | 0.4938 |
Echinococcus granulosus | lamin dm0 | 0.0029 | 0.2862 | 0.2862 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 1.8 uM | PUBCHEM_BIOASSAY: SAR analysis of Antagonists of XIAP-Bir3 domain of IAP-family anti-apoptotic proteins. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1018, AID1449, AID1513, AID1514, AID1638] | ChEMBL. | No reference |
IC50 (binding) | = 4.8 uM | PUBCHEM_BIOASSAY: SAR analysis of Antagonists of IAP-family anti-apoptotic proteins. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1018, AID1449, AID1513, AID1514, AID1638] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.